Type | Public | |
Founded | 2009 | |
HQ | Rockville, MD, US | Map |
Website | regenxbio.com | |
Overall Culture | A+ | More |
USD | |
---|---|
Revenue (Q3, 2020) | 98.9m |
Gross profit (Q3, 2020) | 81.5m |
Gross profit margin (Q3, 2020), % | 82.4% |
Net income (Q3, 2020) | 8.8m |
EBIT (Q3, 2020) | 14.0m |
Market capitalization (5-Feb-2021) | 2.0b |
Closing stock price (5-Feb-2021) | 46.3 |
Cash (30-Sept-2020) | 93.2m |
EV | 1.9b |
USD | Q3, 2015 | Q1, 2016 | Q2, 2016 | Q3, 2016 | Q1, 2017 | Q2, 2017 | Q3, 2017 | Q1, 2018 | Q2, 2018 | Q3, 2018 | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 | Q2, 2020 | Q3, 2020 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 1.1m | 393.0k | 2.4m | 125.0k | 455.0k | 6.6m | 1.3m | 132.4m | 40.0m | 5.3m | 884.0k | 7.9m | 14.7m | 17.6m | 16.6m | 98.9m |
Cost of goods sold | 44.0k | 30.0k | 49.0k | 22.0k | 6.0k | 3.9m | 517.0k | 29.0k | 1.9m | 2.5m | 3.4m | 4.7m | 17.4m | |||
Gross profit | 1.1m | 363.0k | 2.3m | 103.0k | 6.6m | 36.2m | 4.8m | 855.0k | 6.0m | 12.2m | 14.2m | 11.9m | 81.5m | |||
Gross profit Margin, % | 96% | 92% | 98% | 82% | 100% | 90% | 90% | 97% | 76% | 83% | 81% | 72% | 82% |
USD | Q3, 2015 | Q1, 2016 | Q2, 2016 | Q3, 2016 | Q1, 2017 | Q2, 2017 | Q3, 2017 | Q1, 2018 | Q2, 2018 | Q3, 2018 | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 | Q2, 2020 | Q3, 2020 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash | 205.3m | 35.5m | 30.1m | 28.1m | 82.0m | 57.6m | 59.9m | 71.9m | 106.9m | 142.4m | 55.9m | 55.1m | 79.6m | 69.4m | 94.2m | 93.2m |
Accounts Receivable | 2.0m | 783.0k | 679.0k | 228.0k | 50.0k | 884.0k | 26.0m | 739.0k | 2.6m | 8.4m | 9.7m | 19.2m | 44.5m | 42.9m | 122.1m | |
Prepaid Expenses | 1.4m | 1.2m | 1.5m | 2.2m | 1.8m | 2.4m | 3.2m | 4.7m | 6.3m | 6.0m | 6.9m | 7.4m | 9.7m | 16.1m | ||
Current Assets | 215.5m | 105.6m | 97.9m | 96.6m | 148.8m | 165.8m | 172.2m | 262.7m | 293.3m | 386.4m | 303.9m | 359.5m | 360.2m | 338.2m | 329.1m | 387.0m |
USD | Q3, 2015 | Q1, 2016 | Q2, 2016 | Q3, 2016 | Q1, 2017 | Q2, 2017 | Q3, 2017 | Q1, 2018 | Q2, 2018 | Q3, 2018 | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 | Q2, 2020 | Q3, 2020 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | (17.6m) | (10.8m) | (25.2m) | (43.4m) | (22.0m) | (36.5m) | (57.2m) | 104.2m | 114.8m | 95.6m | (32.2m) | (33.7m) | (68.3m) | (40.0m) | (73.8m) | (65.0m) |
Depreciation and Amortization | 43.0k | 48.0k | 104.0k | 264.0k | 554.0k | 1.3m | 2.0m | 834.0k | 1.7m | 2.7m | 1.6m | 3.4m | 5.2m | 2.0m | 4.1m | 6.3m |
Accounts Payable | 317.0k | (182.0k) | 930.0k | 3.6m | 2.5m | 2.7m | 1.1m | 477.0k | (340.0k) | 156.0k | 316.0k | 1.8m | 5.3m | 3.1m | 4.1m | 9.9m |
Cash From Operating Activities | (18.1m) | (7.9m) | (16.3m) | (28.1m) | (17.5m) | (27.0m) | (44.2m) | 58.1m | 128.3m | 108.8m | (29.3m) | (53.0m) | (82.2m) | (35.6m) | (57.1m) | (93.5m) |
USD | Q3, 2015 |
---|---|
Financial Leverage | 1 x |
Regenxbio has 1.38k Twitter Followers. The number of followers has increased 2.9% month over month and increased 11.7% quarter over quarter
241
Tweets
173
Following
1.4k
Followers
6
Tweets last 30 days
2.7
Avg. likes per Tweet
83.3%
Tweets with engagement
A+
91/100
A+
100/100
A+
95/100
When was Regenxbio founded?
Regenxbio was founded in 2009.
Who are Regenxbio key executives?
Regenxbio's key executives are Olivier Danos, Allan Fox and Vit Vasista.
How many employees does Regenxbio have?
Regenxbio has 257 employees.
What is Regenxbio revenue?
Latest Regenxbio annual revenue is $35.2 m.
What is Regenxbio revenue per employee?
Latest Regenxbio revenue per employee is $137.1 k.
Who are Regenxbio competitors?
Competitors of Regenxbio include Evotec, BlueRock Therapeutics and Aptamer Group.
Where is Regenxbio headquarters?
Regenxbio headquarters is located at 9600 Blackwell Rd #210, Rockville.
Where are Regenxbio offices?
Regenxbio has an office in Rockville.
How many offices does Regenxbio have?
Regenxbio has 1 office.
Receive alerts for 300+ data fields across thousands of companies